▼ 1.46%
prev close
Monday.com Ltd is an artificial intelligence work platform that runs and orchestrates the core of all work. The platform democratizes access to software, including AI, enabling organizations to easily build applications and work management tools that fit their needs. The cloud-based platform is a no-code and low-code framework built from modular building blocks that are simple enough for anyone to use, yet powerful enough to drive core business across any organization. The platform also integrates with other systems and applications, creating a connective layer for organizations that links departments and bridges information silos. In addition to the core products, it introduced four core Al work capabilities: monday sidekick, monday vibe, monday agents, and workflows.
Congressional Trades
2
All tracked trades
Members Trading
2
Unique members
Net Activity
+2
2 buys · 0 sells
Members Who Traded This Stock
2 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-02-11 | MNDYmonday.com Ltd. - Ordinary Shares | Buy | $1,001 - $15,000 | 391d ago | — | |
| 2024-11-08 | MNDYmonday.com Ltd. - Ordinary Shares | Buy | $1,001 - $15,000 | 468d ago | — |
2025-02-11
Rob Bresnahan
MNDY
Amount
$1,001 - $15,000
Filed
391d ago
2024-11-08
Michael Patrick Guest
MNDY
Amount
$1,001 - $15,000
Filed
468d ago
Recent News
Powered by Polygon.io
Deadline Alert: monday.com Ltd. (MNDY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
ROSEN, A LEADING LAW FIRM, Encourages monday.com Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MNDY
ROSEN, LEADING INVESTOR COUNSEL, Encourages Hercules Capital, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HTGC
ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
Trade Timeline
Congressional activity, newest first
Rob Bresnahan
2025-02-11 · Purchase
$1,001 - $15,000
Michael Patrick Guest
2024-11-08 · Purchase
$1,001 - $15,000